GLG LLC’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-174,136
Closed -$5.08M 451
2017
Q3
$5.08M Sell
174,136
-16,189
-9% -$447K 0.33% 84
2017
Q2
$5.28M Sell
190,325
-22,122
-10% -$587K 0.32% 87
2017
Q1
$5.28M Buy
212,447
+193,237
+1,006% +$4.7M 0.29% 97
2016
Q4
$416K Sell
19,210
-48,778
-72% -$1.06M 0.03% 434
2016
Q3
$1.62M Sell
67,988
-3,578
-5% -$85.4K 0.12% 198
2016
Q2
$1.67M Sell
71,566
-1,990
-3% -$43.1K 0.13% 184
2016
Q1
$1.38M Sell
73,556
-13,027
-15% -$229K 0.09% 243
2015
Q4
$1.6M Sell
86,583
-49,750
-36% -$891K 0.1% 220
2015
Q3
$2.24M Sell
136,333
-245
-0.2% -$4.19K 0.06% 286
2015
Q2
$2.42M Sell
136,578
-525
-0.4% -$9.38K 0.05% 329
2015
Q1
$2.43M Sell
137,103
-538
-0.4% -$8.5K 0.07% 301
2014
Q4
$1.82M Sell
137,641
-244,459
-64% -$3.13M 0.05% 342
2014
Q3
$4.51M Hold
382,100
0.12% 227
2014
Q2
$4.88M Buy
382,100
+102,148
+36% +$1.33M 0.14% 206
2014
Q1
$3.79M Buy
+279,952
New +$3.67M 0.13% 216

Other funds holding BSX

GLG LLC's BSX Position: Q4 2017 in Review

GLG LLC sold out of Boston Scientific (BSX) in Q4 2017, closing a stake of 174,136 shares — an estimated $5.08M sold.

GLG LLC first reported a position in BSX in Q1 2014 and held it in 15 quarters. The position peaked at $5.28M in Q1 2017. 632 funds tracked by Wall St. Rank hold BSX as of Q4 2017.

  • GLG LLC reported no remaining Boston Scientific position as of Q4 2017 after selling out during the quarter.
  • GLG LLC sold 174,136 Boston Scientific shares in Q4 2017, an estimated $5.08M.
  • GLG LLC first reported a position in Boston Scientific in Q1 2014 and held it in 15 quarters.
  • GLG LLC's Boston Scientific position peaked at $5.28M in Q1 2017.
  • 632 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2017.

Based on GLG LLC's 13F filing for Q4 2017, filed 14 Feb 2018.